Gene · 7306
NIH grants1,707
NIH grants whose papers are about the gene, through NIH's grant-paper links.
61 to 80 of 1,707
Download this page as JSON| Grant | Title | TYRP1 papers | Newest fiscal year |
|---|---|---|---|
| R13AR009431 | Montagna Symposium on the Biology of Skin | 2 | 2025 |
| R35CA196620 | Molecular mechanisms of antibody-mediated immunotherapies | 2 | 2025 |
| T32AI007496 | Interdisciplinary Training Program in Immunology | 2 | 2025 |
| T32AI132165 | PhD Training Program in Virology and Gene Therapy | 2 | 2025 |
| T32CA009207 | Investigational Cancer Therapeutics Training Program (ICTTP) | 2 | 2025 |
| T32ES019851 | Translational Research Training Program in Environmental Health Sciences | 2 | 2025 |
| T32HL007971 | Training grant in hemostasis and thrombosis | 2 | 2025 |
| T32NS007222 | Training in Clinical and Basic Neuroscience | 2 | 2025 |
| U01CA254886 | Live cell reporters of genetic changes in stiff vs soft surroundings - Causes & Consequences | 2 | 2025 |
| ZIAEY000533 | Developing functional and authenticated RPE tissue from iPS cells | 2 | 2025 |
| ZIAEY000542 | Developing autologous iPSC-RPE based IND for AMD patients | 2 | 2025 |
| ZIAHD001607 | Protein Trafficking In The Endosomal-Lysosomal System | 2 | 2025 |
| ZIAHL002541 | Characterization of the Pathogenesis of Lymphangioleiomyomatosis (LAM) | 2 | 2025 |
| ZICEB000085 | Scanning Probe Microscopy for the Intramural Research Community | 2 | 2025 |
| ZICEY000478 | National Ophthalmic Disease Genotyping and Phenotyping Network - eyeGENE | 2 | 2025 |
| ZIDHG200352 | NHGRI/DIR Clinical Support Services | 2 | 2025 |
| I01BX001409 | REGULATORS OF EPITHELIAL TUMOR PROGRESSION | 1 | 2025 |
| I01BX004121 | RadIO: A Novel Radiomics Toolkit to Predict and Characterize Response to Immunotherapy in Stage III Non-Small Cell Lung Cancer | 1 | 2025 |
| K08AR078251 | Mechanisms of sex discrepancy in autoimmune disease: Regulation of the female-biased VGLL3 immune pathway | 1 | 2025 |
| K08HL166690 | From genotype to phenotype in a GWAS locus: the role of REST in atherosclerosis | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7306/grants?page=4